DOVATO is indicated for the treatment of Human Immunodeficiency Virus (HIV) infection in adults and adolescents from 12 years of age weighing at least 40 kg, who have no known or suspected resistance to either antiretroviral component.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
